Drug
Cinpanemab clinical trials
Also written BIIB054.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How studies write it
Studies that test it under each name
Development codes
- BIIB054
- 3
Studies by the year they started
3 studies that test it; most in 2015 (1)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses cinpanemab is read from its arms, and is right about nine times in ten.
Testing it · 3
- Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's DiseaseTerminatedPhase 2BiogenNCT03318523Written as BIIB054
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Japanese Participants With Parkinson's DiseaseTerminatedPhase 1BiogenNCT03716570Written as BIIB054
- Single-Ascending Dose Study of BIIB054 in Healthy Participants and Early Parkinson's DiseaseCompletedPhase 1BiogenNCT02459886Written as BIIB054
Codes
What other systems call cinpanemab · ClinicalTrials.gg INT018328
- UNII (FDA) W83JGQ40XXCINPANEMABOne source FDA
- NCI Thesaurus C169852CinpanemabOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | W83JGQ40XX | CINPANEMAB | One source FDA |
| NCI Thesaurus | C169852 | Cinpanemab | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.